ArticleOphthalmology science2026
Tobacco Exposure and Risk of Developing Fuchs Endothelial Corneal Dystrophy in the Women's Health Initiative Studies.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between Self-Reported Smoking Behaviour and Fuchs Endothelial Corneal Dystrophy: A Cross-Sectional Analysis.AJO international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: We prospectively examined the association between tobacco exposure (personal/secondhand smoking [SHS]) and Fuchs endothelial corneal dystrophy (FECD) in older women, the group most impacted by FECD. Design: We conducted a secondary data analysis utilizing the Women's Health Initiative's (WHI's) Observational Study and Clinical Trials data. Participants: Postmenopausal women aged >65 who participated in WHI, had available Medicare claims data, and did not have FECD within 1 year after WHI enrollment were included (N = 37 824). Methods: Smoking status, pack-years, and average cigarettes per day were assessed at baseline (1993-1998). Secondhand smoking was assessed by location (childhood or adulthood at home and work). Participant characteristics were compared by personal smoking history and SHS status. Crude and adjusted Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of FECD by personal smoking exposure and by SHS status. Main Outcome Measures: Incident FECD cases were identified objectively via Medicare claims data through 2019. Results: Current smokers compared with never smokers were more likely to be younger, have lower body mass indices, and were less likely to be White, married, and users of hormone replacement therapy. Current smokers had an increased risk of FECD compared with never smokers (HR = 1.12, CIs: 0.90-1.38) and former smokers had a slight decreased risk of FECD compared with never smokers (HR = 0.92, CIs: 0.84-1.01). Current smokers who smoked ≥15 cigarettes/day had a 26.0% (HR = 1.26, CIs: 0.94-1.68) greater risk of developing FECD compared with never smokers. However, former smokers who smoked ≥15 cigarettes/day had a 14.0% (HR = 0.86, CIs: 0.76-0.97) reduced risk of developing FECD compared with never smokers. Most women (93.6%) were exposed to SHS sometime in their life. Never smokers exposed to SHS at home during childhood or adulthood had approximately a 22%-25% nonsignificant increased risk of developing FECD compared with never smokers without SHS exposure. Conclusions: In this sample of postmenopausal women, personal smoking and SHS were not significantly associated with increased risk of FECD, but suggestions of an increased risk were observed in current smokers. Our findings may have been impacted by lack of variation in exposures, survival, and sick-quitter biases. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.